Cartesian Therapeutics, Inc. RNAC
6.12 USD +0.04 (+0.66%)
Regular-session close
6.12 0.00 0.00%
After hours · Nov 17, 4:00 PM ET
5.89 Day range 6.24
5.60 52-week range 11.00
- YTD
- -15.12%
- 1 year
- -17.07%
News
zacks.com Bears are Losing Control Over Cartesian Therapeutics, Inc. (RNAC), Here's Why It's a 'Buy' Now Cartesian Therapeutics, Inc. (RNAC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate…
zacks.com Wall Street Analysts See a 379.63% Upside in Cartesian Therapeutics, Inc. (RNAC): Can the Stock Really Move This High? The consensus price target hints at a 379.6% upside potential for Cartesian Therapeutics, Inc. (RNAC). While empirical research shows that this sought-after metric is hardly effective, an upward…benzinga.com Cartesian Therapeutics Q3 EPS $(0.38) Beats $(0.95) Estimate Cartesian Therapeutics (NASDAQ:RNAC) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.95) by 60 percent. This is a 72.46 percent increase over losses of…
